A phase I study to compare the bioavailability and pharmacokinetics of fentanyl after administration of a single dose of a Fentanyl MDTS and a Durogesic 25 patch in pain

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12605000526673

Enrollment

Registered

2005-09-26

Start date

2003-03-14

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Fentanyl MDTS and Durogesic 25 patch for single dose, Naltrexone daily for three days.

Study design

Allocation

Randomised controlled trial

Intervention model

Crossover

Primary purpose

Treatment

Masking

Open (masking not used)

Eligibility

Sex/Gender

Male

Age

0 to No maximum

Healthy volunteers

Yes

Inclusion criteria

Healthy volunteers

Exclusion criteria

No exclusion criteria

Outcome results